The fallout for Venture Global Inc., in the wake of a troubled initial public offering, accelerated amid a market selloff ...

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Even so the deal solidifies Venture Global’s place in the public markets with an impressive $50 billion market cap. And it ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

The U.S. IPO market is moving forward with a steady flow of applicants. Investors this week are awaiting the U.S. Fed's ...

The IPO trend remains robust in 2025, driven by strong retail investor interest and a shift from FPIs to the primary market.

Learn about Karman Holdings' upcoming $100 million US IPO, their focus on missile and space systems, and the financial ...

Rexpro Enterprises IPO shows a grey market premium of ₹10, indicating a potential listing price of ₹155. The IPO was ...

Domestic investors will be reacting to Q3 results from several companies, including Tata Steel, Bajaj Housing Finance, Coal ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Steel products maker Colform Group Bhd’s initial public offering (IPO) of 30 million shares has been oversubscribed by 41.82 ...